使用220 kHz经颅磁共振成像引导聚焦超声与5-氨基乙酰丙酸对恶性胶质瘤进行声动力治疗
本研究在体外和体内评估220 kHz经颅磁共振成像引导聚焦超声(TcMRgFUS)联合5-氨基乙酰丙酸(5-ALA)对恶性胶质瘤的声动力治疗(SDT)效果。F98细胞经200 µg/mL 5-ALA处理后接受聚焦超声照射,显示联合处理通过诱导凋亡降低细胞活力。体内实验显示联合治疗抑制肿瘤增殖、侵袭和血管生成,对正常脑组织损伤最小,作者认为该方案可安全用于恶性胶质瘤治疗。
要点
- 220 kHz TcMRgFUS联合5-ALA的SDT在体外降低F98细胞活力并诱导凋亡。
- 体内研究显示联合治疗抑制肿瘤增殖、侵袭和血管生成,对正常脑组织损伤最小。
- 作者认为该方案可安全用于恶性胶质瘤治疗。
核心结论
- 220 kHz TcMRgFUS联合5-ALA的声动力治疗可安全用于恶性胶质瘤治疗,并在体外和体内显示抗肿瘤效果。
研究设计与样本
- 体外与体内实验研究;F98细胞经200 µg/mL 5-ALA处理后接受聚焦超声照射(4000 J、20 W、240 s、100%占空比、靶介质温度<40°C),20小时后评估细胞活力和凋亡;体内实验评估5-ALA联合聚焦超声(500 J、18 W、30 s、100%占空比、重复10次、靶组织温度≤42°C)治疗前后MRI肿瘤体积变化及组织病理学分析。
关键影像表现/征象
- FUS/5-ALA联合处理降低细胞活力并诱导凋亡。
- 体内联合治疗抑制肿瘤增殖、侵袭和血管生成。
- 联合治疗对正常脑组织损伤最小。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Sonodynamic therapy (SDT) is used to treat various malignancies and can be applied to brain tumors using a transcranial magnetic resonance imaging-guided focused ultrasound (TcMRgFUS) device. This study investigated the efficacy of 220-kHz TcMRgFUS combined with 5-aminolevulinic acid (5-ALA) on malignant glioma in vitro and in vivo. F98 cells were irradiated with focused ultrasound (FUS) (4000 J, 20 W, 240 s, 100% duty cycle, target medium temperature <40°C) after treatment with 200 µg/mL 5-ALA, and cell viability and apoptosis were evaluated with the water-soluble tetrazolium-1 assay, triple fluorescent staining and Western blot analysis 20 h later. The anti-tumor effects of 5-ALA combined with FUS (500 J, 18 W, 30 s, 100% duty cycle, 10 repeats, target tissue temperature ≤42°C) were assessed on the basis of changes in tumor volume determined by MRI and histopathological analysis before and after treatment. The FUS/5-ALA combination reduced cell viability by inducing apoptosis and suppressed tumor proliferation and invasion as well as angiogenesis in vivo, while causing minimal damage to normal brain tissue. SDT with 220-kHz TcMRgFUS and 5-ALA can be safely used for the treatment of malignant glioma.
引用
- Yoshida M, Kobayashi H, Terasaka S, et al. Sonodynamic Therapy for Malignant Glioma Using 220-kHz Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound and 5-Aminolevulinic acid. Ultrasound Med Biol. 2018. PMID: 30522817. doi:10.1016/j.ultrasmedbio.2018.10.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。